US FDA pushes for mandatory electronic AE reporting.

The article reports on the proposed amendments issued by the U.S. Food & Drug Administration (FDA) for mandatory electronic adverse event (AE) reporting. It relates the benefits of the electronic AE reporting. It presents remarks of Office of Surveillance and Epidemiology Director Gerald Dal Pan on the issue. The options for the electronic submission of reports are also cited.